Myomo Achieves Record Revenue and Adjusted EBITDA Break-even in Q3 2026
MYO Myomo Inc
$1.40 +15.70%
View chart & analysis → - 1Myomo recorded quarterly revenue of $12.3 million in Q3 2026.
- 2Revenue from recurrent patient sources accounted for 54% of Myomo's Q3 revenue.
- 3Myomo recorded a gross margin of 71.3% in Q3 2026.
So what's the key point?
Myomo generated $12.3 million in revenue during the third quarter of 2026. Revenue from recurrent patients exceeded 54%, meaning the company has started to turn a profit.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.